AptarGroup

Next-Generation Personalized Beauty Global Market Analysis Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Monday, July 18, 2022
Specialty, Retail, Hers, Skin, Hims & Hers Health, Acquisition, Dermatology, Woman, Blister, Solution, Pachydactylus labialis, Apostrophe, AptarGroup, Environment, Beauty, Skin care, Acne, Organization, Medscape, Hair loss, Growth, Health, Pain, Globe, Partnership, Man, Skin condition, Beauty salon, Cosmetics

The "Next-Generation Personalized Beauty Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Next-Generation Personalized Beauty Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • The next-generation personalized beauty market consists of sales of next-generation personalized beauty services and products by entities (organizations, sole traders, and partnerships) that are involved in personalized beauty.
  • Next-generation personalized beauty includes products and services that are personalized or designed according to the needs of every individual.
  • Global Next-Generation Personalized Beauty Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Aptar Declares Quarterly Dividend

Retrieved on: 
Wednesday, July 13, 2022
Packaging, Health, Manufacturing, Other Health, Other Manufacturing, Pharmaceutical, Security (finance), Central Time, Result, U.S. Securities and Exchange Commission, Science, Food, Engineering, Beauty, Drug Quality and Security Act, AptarGroup, Patient, Securities Exchange Act of 1934, Form, ATR, Investor, Analysis, Financial condition report, Forward-looking statement, Interest, Health, NYSE, Securities Act of 1933

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share.

Key Points: 
  • AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share.
  • As previously announced, Aptar will hold a conference call on Friday, July 29, 2022 at 8:00 a.m. Central Time to discuss the Companys second quarter results for 2022.
  • Aptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions and services.
  • Aptar is headquartered in Crystal Lake, Illinois and has 13,000 dedicated employees in 20 countries.

Aptar Releases 2021 Corporate Sustainability / ESG Report

Retrieved on: 
Wednesday, June 22, 2022
Environment, Packaging, Chemicals, Plastics, Professional Services, Manufacturing, Sustainability, Health, Pharmaceutical, Environmental, Social and Governance (ESG), Solution, Communication, Global Compact, Progress, Carbon, Science, Global, Workplace, CEO, United Nations Global Compact, MacArthur, Engineering, Corporate sustainability, GRI, Recycling, Health, Ellen, World Business Council for Sustainable Development, Platinum, AptarGroup, Food, Beauty, Patient, Sustainable development, ESG, Multimedia, NYSE, Global Sustainability Assessment System, ATR, Lithium

Aptars 2021 Corporate Sustainability / ESG Report highlights activities across the Companys global operations and summarizes milestones measured and achieved in the key areas of its global sustainability strategy.

Key Points: 
  • Aptars 2021 Corporate Sustainability / ESG Report highlights activities across the Companys global operations and summarizes milestones measured and achieved in the key areas of its global sustainability strategy.
  • View the full release here: https://www.businesswire.com/news/home/20220622005928/en/
    Aptars 2021 Corporate Sustainability / ESG Report.
  • Following the commitment to the United Nations Global Compact in 2020, Aptar is publishing its second UN Global Compact Communication on Progress Report alongside the 2021 Corporate Sustainability / ESG Report.
  • The Aptar 2021 Corporate Sustainability / ESG Report is prepared in accordance with the Global Reporting Initiative (GRI) Standards: Core option.

Opiant Pharmaceuticals and Aptar Pharma Expand Long-Term Collaboration for the Manufacture of Unidose Nasal Spray for OPNT003, Nasal Nalmefene

Retrieved on: 
Wednesday, June 8, 2022
Regulation of tobacco by the U.S. Food and Drug Administration, Drug overdose, Emergency, Media, Risk, FDA, GLOBE, Fast track (FDA), Administration, NASDAQ, NDA, AptarGroup, Terminology, Pharmaceutical industry, Renewable energy, Risk management

SANTA MONICA, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc.(Opiant) (NASDAQ: OPNT) today announced a capacity investment agreement with Aptar Pharma (Aptar), a leading provider of drug delivery systems,to expand production of Aptars nasal Unidose device, which will be used in the production of commercial supply of OPNT003, nasal nalmefene.

Key Points: 
  • SANTA MONICA, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc.(Opiant) (NASDAQ: OPNT) today announced a capacity investment agreement with Aptar Pharma (Aptar), a leading provider of drug delivery systems,to expand production of Aptars nasal Unidose device, which will be used in the production of commercial supply of OPNT003, nasal nalmefene.
  • This capacity investment with Aptar demonstrates Opiants commitment to ensure adequate supply of OPNT003, nasal nalmefene, to communities and emergency responders as quickly as possible, if approved, saidRoger Crystal, M.D., President and Chief Executive Officer of Opiant.
  • Opiant has initiated rolling submission of a New Drug Application to the U.S Food and Drug Administration (FDA), for OPNT003, nasal nalmefene, for the treatment of opioid overdose, using the 505(b)(2) pathway.
  • Opiant Pharmaceuticals, Inc., the company that developed NARCAN Nasal Spray, is building a leadingfranchiseof new medicines to combat addictions and drug overdose.

Aptar Named Among the 100 Best Corporate Citizens for 2022

Retrieved on: 
Wednesday, May 18, 2022
Manufacturing, Environment, Health, Pharmaceutical, Packaging, Engineering, Form, Human rights, U.S. Securities and Exchange Commission, Beauty, Food, Multimedia, Science, Goal, Patient, Financial condition report, Result, AptarGroup, NGO, Health, Securities Act of 1933, Securities Exchange Act of 1934, Industry, Partnership, Forward-looking statement, Institutional Shareholder Services, Personal Data Privacy and Security Act of 2009, Security (finance), Climate change, Employment, Responsibility, ISS, ATR, NYSE, CEO, Analysis, ESG, Management, Risk management, Environment

3BL Media, in partnership with Institutional Shareholder Services (ISS) ESG, evaluated the 1,000 largest public U.S. companies regarding ESG and Aptar is among the top 100 companies.

Key Points: 
  • 3BL Media, in partnership with Institutional Shareholder Services (ISS) ESG, evaluated the 1,000 largest public U.S. companies regarding ESG and Aptar is among the top 100 companies.
  • View the full release here: https://www.businesswire.com/news/home/20220518006055/en/
    We are honored to be named one of the best corporate citizens for the second year in a row.
  • 3BL Media formulates its methodology based on the latest developments in corporate sustainability, extensive feedback from corporate and NGO stakeholders and guidance from Institutional Shareholder Services (ISS) ESG.
  • To view the complete 100 Best Corporate Citizens of 2022 list, please visit https://100best.3blmedia.com/ .

Global Cosmetic Packaging Market Forecast Report 2021-2022 & 2028: Rise in Sustainable and Eco-Friendly Packaging & Opportunities in Product Innovations - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 4, 2022
Packaging, Cosmetics, Retail, Manufacturing, COVID-19, Printing, Dust, YouTube, Instagram, Microplastics, US, Polyethylene, Beauty, Natural gas, Glass, Paper, APC, AptarGroup, Cosmetics, Plant, Plastic, CAGR, HCP, Technology, Application, PP, Growth, Foundation, Social media, PET, Video game, Facebook

The "Cosmetic Packaging Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Material and Application" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cosmetic Packaging Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Material and Application" report has been added to ResearchAndMarkets.com's offering.
  • The growth of the cosmetic packaging market is driven by various innovative solutions, such as package printing technology.
  • Based on material, the cosmetic packaging market is segmented into glass, plastic, paper, metal, and others.
  • The companies have their presence in the developing regions, which provides lucrative opportunities for the cosmetic packaging market growth.

Aptar Declares Quarterly Dividend

Retrieved on: 
Thursday, April 14, 2022
Packaging, Pharmaceutical, Health, Manufacturing, AptarGroup, Central Time, U.S. Securities and Exchange Commission, Security (finance), Interest, Science, ATR, Analysis, Patient, Drug Quality and Security Act, Engineering, Securities Exchange Act of 1934, Food, Form, Beauty, Forward-looking statement, NYSE, Result, Securities Act of 1933, Health, Financial condition report, Investor

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share.

Key Points: 
  • AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share.
  • As previously announced, Aptar will hold a conference call on Friday, April 29, 2022 at 8:00 a.m. Central Time to discuss the Companys first quarter results for 2022.
  • Aptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions and services.
  • Aptar is headquartered in Crystal Lake, Illinois and has 13,000 dedicated employees in 20 countries.

Aptar Announces Passing of Director Jesse Wu

Retrieved on: 
Monday, April 11, 2022
Packaging, Pharmaceutical, Health, Manufacturing, Company, Family, Personality, Multimedia, Board, NYSE, Management development, AptarGroup, ATR, CEO, Health, Director, Financial compensation, Science, Beauty, Engineering, Food, Patient, Management

AptarGroup, Inc. (NYSE: ATR) today announced with deep sadness that Jesse Wu, a director of the Company, has passed away.

Key Points: 
  • AptarGroup, Inc. (NYSE: ATR) today announced with deep sadness that Jesse Wu, a director of the Company, has passed away.
  • Mr. Wu served on the Board of Directors since 2018 and was a member of the Management Development & Compensation Committee.
  • View the full release here: https://www.businesswire.com/news/home/20220411005279/en/
    Jesse Wu, Aptar Director and Member of the Management Development & Compensation Committee (Photo: Aptar)
    Jesse was a valued member of our Board and wonderful colleague.
  • Aptar is headquartered in Crystal Lake, Illinois and has 13,000 dedicated employees in 20 countries.

Owen Mumford And Noble International Announce Collaboration On Patient Training Solutions For UniSafe® Drug Delivery Devices

Retrieved on: 
Tuesday, March 29, 2022
Business development, Noble, AptarGroup, Safety, Nobles International School, Solution, Engineering, Patient, Syringe, Pharmaceutical industry, Fine chemical

APOPKA, Fla., March 29, 2022 /PRNewswire-PRWeb/ -- Owen Mumford Pharmaceutical Services, a division of Owen Mumford Ltd, which specialises in the design, development and manufacture of injectable drug delivery systems for the pharmaceutical, biotech and generics industries, announces its alliance with Noble International, an Aptar Pharma company and world leader in providing drug delivery training device programs for pharmaceutical companies and original equipment manufacturers.

Key Points: 
  • Through this agreement, Noble will develop patient-focused training devices for Owen Mumford's safety syringe platform UniSafe.
  • Through this agreement, Noble will develop patient-focused training devices for Owen Mumford's safety syringe platform UniSafe.
  • 1
    "We understand the need for comprehensive training for drug delivery devices, especially for new patients or those with dexterity challenges.
  • Noble's training solutions encompass drug delivery training devices that mimic the exact feel, force and function of the real drug delivery device on which it is modeled, and include autoinjectors, prefilled syringes, nasal devices and pulmonary devices.

Cosmetic Packaging Market size worth $ 53.78 Billion, Globally, by 2028 at 5.76% CAGR: Verified Market Research®

Retrieved on: 
Thursday, March 17, 2022
Market research, Cosmetics, CAGR, DS Smith, USD, AptarGroup, Metal, Growth, Container, Paper, United States Secretary of Labor, Glass, Government, Silgan Holdings, Hair care, Ageing, Geography, Beauty, Awareness, Efficiency, Food, Application, Plastic

According to Verified Market Research, the Global Cosmetic Packaging Market size was valued at USD 34.98 Billion in 2020 and is projected to reach USD 53.78 Billion by 2028, growing at a CAGR of 5.76% from 2021 to 2028.

Key Points: 
  • According to Verified Market Research, the Global Cosmetic Packaging Market size was valued at USD 34.98 Billion in 2020 and is projected to reach USD 53.78 Billion by 2028, growing at a CAGR of 5.76% from 2021 to 2028.
  • With a larger number of brands and products opening the Cosmetic Packaging Market, packaging efficiency, and demand for product differentiation are some of the factors driving the market growth.
  • Furthermore, the growing aging population factors have positively anticipated in propelling the growth of the global Cosmetic Packaging Market.
  • Verified Market Research has segmented the Global Cosmetic Packaging Market On the basis of Type, Material, Application, and Geography.